YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Major earnings expected after the bell on Monday include: * ABIVAX Societe Anonyme (ABVX [https://seekingalpha.com/symbol/ABVX]) * For Seeking Alpha's full earnings season calendar, click here [https://seekingalpha.com/earnings/earnings-ca…
M&A activity in the biotech sector has accelerated sharply in 2026, as large drugmakers increasingly turn to external innovation to strengthen pipelines, expand into new therapeutic areas and gain access to promising technologies and late-…
DelveInsight Business Research LLP Emerging therapies for ulcerative colitis treatment, such as Obefazimod (Abivax), Tulisokibart (Merck), Olamkicept (Ferring Pharmaceuticals), Afimkibart (Roche), Icotrokinra (Johnson & Johnson/Protagonist…
[Medical research with pipette and test tube, DNA analysis, biotechnology, genetic science and healthcare] jittawit.21 Big Pharma moved back into the spotlight last week following a Financial Times report that Bristol Myers Squibb (BMY [ht…
Study to evaluate rupitasertib, Evexta Bio's first-in-class oral dual-node, S6K and AKT1/3 inhibitor in combination with giredestrant in second-line ER+, HER2-, ESR1-mutated advanced / metastatic breast cancer; expected to initiate in Q4 2…
The inflammatory bowel disease market is experiencing sustained growth, driven by the rising prevalence of Crohn's disease and ulcerative colitis, increasing disease awareness, and earlier diagnosis. Additionally, the launch of emerging th…
"Buy low" is a common investing phrase that some people may interpret as "buy after a pullback." However, even near all-time highs, a stock can be at a "low" point, provided there are good reasons to think it will continue performing well.…
Key Points Abivax's shares could rise even further as it advances a candidate poised to disrupt a large market. Krystal Biotech's strong financial results and deep pipeline make its prospects attractive. Marvell Technology has only begun t…
Key Points Interested in Abivax SA Sponsored ADR? Here are five stocks we like better. Abivax shares rose more than 40% in a month after positive Phase 3 trial results for Obefazimod, a proposed ulcerative colitis maintenance treatment, an…
Abivax (ABVX) shares have rebounded to pre-Phase 3 maintenance data levels as investor concerns over PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Is ABVX a good stock to buy? We came across a bullish thesis on ABIVAX Société Anonyme on R. Dennis's Substack by OppCost. In this article, we will summarize the bulls' thesis on ABVX. ABIVAX Société Anonyme's share was trading at $133.26…
Investing.com -- Jefferies upgraded Abivax to "Buy" from "Hold" and raised its price target to $158 from $108 after updated Phase 3 data for its lead drug candidate, obefazimod, alleviated concerns over previously reported malignancy cases…
Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares Upsized offering increased from the previously announced $600M to $800M at $125.00 per ADS, priced at a 2.39% premium…
(RTTNews) - Wednesday, ABIVAX Société Anonyme (ABVX) announced the pricing of an underwritten public offering of 6.4 million American Depositary Shares or ADSs, each representing one ordinary share, 0.01 nominal value per share, of the com…
Quick Read All four major U.S. indices posted their best first-half performances in years, but stocks enter Q3 overbought with the Magnificent 7 underperforming. Citigroup upgraded LMT to Buy with a $582 target, while Guggenheim raised bot…
(RTTNews) - Abivax SA (ABVX, ABVX.PA), a clinical-stage biotechnology company, announced on Wednesday that trading of its shares on the Euronext Paris market will be temporarily halted, at the company's request, from the opening of the mar…
Abivax announces temporary trading halt of its ordinary shares on Euronext Paris PARIS, France, July 1, 2026 – 07:30 a.m. CEST –Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology com…
(RTTNews) - Today's top gainers in the biotech space include Cuprina, which recently received FDA clearance for its maggot-based wound treatment; ABIVAX, following encouraging results from an ulcerative colitis study; ProMIS, which has a k…
4:15pm: Best quarter since 2020 Wall Street has wrapped up its best quarter since 2020, with the Dow Jones adding another 0.3% on Friday to close at a fresh record of 52,319 points. The Nasdaq was up 1.5% at 26,213 points and the S&P 500 w…
[Stock market activity shows price changes and trading movements in real time] FabrikaCr Stock futures edged higher early Tuesday as traders kept a close watch on impending domestic economic data and volatile Middle Eastern geopolitical dy…
[Female Scientist Performing A Scientific Experiment In A Laboratory, Holding A Petri Dish And Dropper.] Tashi-Delek * Abivax SA (ABVX [https://seekingalpha.com/symbol/ABVX]) shares surged Tuesday premarket after the biotech reported [http…
ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the best young stocks to invest in according to hedge funds. On May 22, Abivax reported Q1 2026 financial results, highlighting a solid cash position of €491.6 million, which provides a runway…
LOS ANGELES, June 17, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Abivax S.A. (“Abivax” or “the Company”) (NASDAQ: ABVX) f…
LOS ANGELES, June 10, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Abivax S.A. (“Abivax” or “the Company”) (NASDAQ: ABVX) f…
As European markets navigate a period of uncertainty marked by economic contractions and fluctuating retail sales, investors are increasingly focused on identifying opportunities that offer attractive valuations. In this context, finding s…
Global markets have been buoyed by optimism surrounding a potential U.S.-Iran peace agreement, with major U.S. stock indexes like the Nasdaq Composite and Russell 2000 reaching record highs, driven in part by enthusiasm for AI-linked stock…
Abivax SA (NASDAQ:ABVX) is one of the 9 Stocks Crushing the Market With Surging Returns. Abivax soared by 16.39 percent on Thursday to close at $104.93 apiece as investors continued to hunt for bargains following the previous days' lows, d…
(RTTNews) - Today's gainers list includes ABIVAX, which recently announced positive ulcerative colitis trial results; Cingulate, which is working toward resubmission of a New Drug Application for an ADHD therapy; and Alpha Tau, following i…
Last year, shares of Abivax(NASDAQ: ABVX), a clinical-stage biotech company based in France, soared after it reported strong phase 3 results for its leading candidate, obefazimod, an investigational medicine for moderate-to-severe ulcerati…
Healthcare stocks declined late Tuesday afternoon, with the NYSE Healthcare Index decreasing 0.8% an PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Abivax Grounded as Cancer Cases Cast a Shadow Over Best-in-Class Trial Data - Moby THE GIST Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap…
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Arete upgraded Meta Platforms(META) to Buy…
Quick Read: Stocks started the week where they left off Friday, with all the major indices except the Russell 2000 closing higher. The S&P 500, looking to post its 10th consecutive week of gains, once again closed at an all-time high on Mo…
(RTTNews) - Abivax SA (ABVX) has reported pivotal Phase 3 ABTECT Maintenance trial, evaluating Obefazimod in adults with moderately to severely active ulcerative colitis. Ulcerative colitis is a chronic inflammatory bowel disease that caus…
Abivax annonce des résultats majeurs de l’essai de maintenance de phase 3 ABTECT évaluant l’obéfazimod dans le traitement de la rectocolite hémorragique active modérée à sévère À la semaine 44, les deux doses d’obéfazimod, 25 mg et 50 mg a…
Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis At Week 44, both the 25 mg and 50 mg once-daily obefazimod doses met the primary endpoint, demonst…